Gilead Sciences to Present at Three Upcoming Investor Conferences in September
September 06 2016 - 1:00PM
Business Wire
- Citi’s 11th Annual Biotech
Conference -
- 2016 Wells Fargo Healthcare Conference
-
- Morgan Stanley Global Healthcare
Conference -
- Webcasts Available Through Gilead
Corporate Website -
Gilead Sciences, Inc. (Nasdaq: GILD) today announced webcasts
from three upcoming investor conferences: Citi’s 11th Annual
Biotech Conference, the 2016 Wells Fargo Healthcare Conference and
the Morgan Stanley Global Healthcare Conference.
Kevin Young CBE, Gilead’s Chief Operating Officer and Norbert W.
Bischofberger, PhD, Gilead’s Executive Vice President, R&D and
Chief Scientific Officer, will participate in fireside chats at
Citi’s 11th Annual Biotech Conference on Wednesday, September 7 at
11:00 a.m. Eastern Time (ET) and the 2016 Wells Fargo Healthcare
Conference on Thursday, September 8 at 9:55 a.m. ET, both taking
place in Boston.
John F. Milligan, PhD, Gilead’s President and Chief Executive
Officer, will participate in a fireside chat at the Morgan Stanley
Global Healthcare Conference on Monday, September 12 at 9:20 a.m.
ET in New York.
The audio portion of the fireside chats will be accessible live
through the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior
to the start of the presentation to ensure adequate time for any
software download that may be required to listen to the webcast.
The replay will be available for 14 days following the
presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160906006192/en/
Gilead Sciences, Inc.Sung Lee, 650-524-7792Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024